Nalaganje...
Next-generation sequencing-based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her-2 and TP53 mutations in patients with non-small cell lung cancer
In recent years, the incidence of non-small cell lung cancer (NSCLC) has become the highest lethal rate of cancer worldwide. Molecular assays of EGFR, KRAS, BRAF, NRAS, PIK3CA and Her-2 are widely used to guide individualized treatment in NSCLC patients. Somatic mutations in 112 NSCLC patients, incl...
Shranjeno v:
| izdano v: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6072231/ https://ncbi.nlm.nih.gov/pubmed/29956783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2018.9210 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|